Inmedix Meets with FDA to Discuss the Development Plan Supporting...

Inmedix, the leader in heart rate variability (HRV) application as an informative diagnostic tool in autoimmune disease, today announced that the FDA has provided guidance for the required development...(PRWeb March 28, 2016)Read the full story at http://www.prweb.com/releases/2016/03/prweb13295192.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news